Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 374

    WHO tells governments to reject Philip Morris-funded smoking foundation

    WHO tells governments to reject Philip Morris-funded smoking foundation

    Ruby Khatun Khatun1 Oct 2017 9:20 AM IST
    GENEVA: The World Health Organization (WHO) told governments on Thursday not to get involved in a foundation funded by tobacco firm Philip Morris...
    Hilleman Labs gets grant to develop oral cholera vaccine

    Hilleman Labs gets grant to develop oral cholera vaccine

    Ruby Khatun Khatun30 Sept 2017 10:57 AM IST
    New Delhi: Hilleman Laboratories, a joint- venture partnership between pharma major MSD and Wellcome Trust, said it has received 6 million krona (over...
    Zydus Cadila gets final nod from USFDA for anti-bacteria drug

    Zydus Cadila gets final nod from USFDA for anti-bacteria drug

    Ruby Khatun Khatun30 Sept 2017 10:14 AM IST
    New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market doxycycline tablets, used for the treatment of...
    Abbott gets FDA approval for blood glucose monitoring system

    Abbott gets FDA approval for blood glucose monitoring system

    Ruby Khatun Khatun30 Sept 2017 10:05 AM IST
    The U.S. Food and Drug Administration (FDA) approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring...
    MD Anderson, Pfizer announce immuno-oncology collaboration

    MD Anderson, Pfizer announce immuno-oncology collaboration

    Ruby Khatun Khatun30 Sept 2017 9:35 AM IST
    The University of Texas MD Anderson Cancer Center and Pfizer Inc. announced that they have entered into a clinical collaboration to study novel...
    Senators want probe of Allergan transfer deal with tribe: letter

    Senators want probe of Allergan transfer deal with tribe: letter

    Ruby Khatun Khatun30 Sept 2017 9:15 AM IST
    Four U.S. senators have asked the Senate Judiciary Committee to launch an investigation into a deal drugmaker Allergan Plc struck with a Native...
    Zydus gets USFDA nod for anti-inflammatory drug

    Zydus gets USFDA nod for anti-inflammatory drug

    Ruby Khatun Khatun29 Sept 2017 10:39 AM IST
    New Delhi: Drug firm Zydus Cadila on Wednesday said it has received final approval from the US health regulator to market indomethacin...
    Divis Labs slumps over 9 percent on USFDA observations

    Divis Labs slumps over 9 percent on USFDA observations

    Ruby Khatun Khatun29 Sept 2017 10:07 AM IST
    New Delhi: Shares of Divis Laboratories Ltd fell as much as 9.4 percent to Rs. 870.1 on USFDA observations.Observations issued by the USFDA on its...
    Novartis forges UC Berkeley pact, sees drug hopefuls in three years

    Novartis forges UC Berkeley pact, sees drug hopefuls in three years

    Ruby Khatun Khatun29 Sept 2017 9:41 AM IST
    ZURICH: Novartis’s NOVN.S research head expects an alliance with a University of California chemistry lab to produce drug candidates within three...
    CVC, others explore sale of drugmaker Alvogen

    CVC, others explore sale of drugmaker Alvogen

    supriya kashyap kashyap29 Sept 2017 9:17 AM IST
    CVC Capital Partners and other private equity owners are exploring options for generic drugmaker Alvogen, including a sale, which could be valued at...
    Glenmark Pharma receives USFDA nod for skin lotion

    Glenmark Pharma receives USFDA nod for skin lotion

    supriya kashyap kashyap28 Sept 2017 11:06 AM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Desonide lotion used to treat skin rashes and...
    Indivior settles addiction treatment case with Mylan for undisclosed terms

    Indivior settles addiction treatment case with Mylan for undisclosed terms

    Ruby Khatun Khatun28 Sept 2017 10:30 AM IST
    Indivior's U.S. subsidiary, together with Monosol Rx, has settled a patent dispute with U.S. drugmaker Mylan related to generic versions of its opioid...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok